A Miami company’s children’s ADHD medicine might not work. There’s a national recall
Four strengths of Daytrana prescription patches, worn to help children and adolescents diagnosed with ADHD, have been recalled nationwide by Noven Pharmaceuticals’ Miami office.
The reason given on the FDA-posted notice: “Defective Delivery System: Out of specification for shear.”
That means testing says the patches don’t deliver the drug within acceptable standards. Noven recalled Daytrana patches in March 2020 for the same reason.
A recall notice sent to pharmacy supplier PBA Health in 2020 said, “The use or exposure to the product could lead to user annoyance, decreased or lack of drug effect, or accidental exposure to caregivers or others.”
READ MORE: Over 710,000 bottles of Clear Eyes eye drops recalled
This recall covers 17 lots over four strengths, each sold in 30-count packs.
▪ 10 mg: lot Nos. 91955, expiration 7/2023, and 93039, expiration 10/2023.
▪ 15 mg: lot Nos. 91956, expiration 6/2023, and 92475, expiration 7/2023.
▪ 20 mg: lot Nos. 91957 and 92197, expiration 7/2023 and 92476, expiration 9/2023; and 92477, expiration 10/2023.
▪ 30 mg: lot Nos. 91474 and 91959, expiration 3/2023; 91958, expiration 6/2023; 92478, expiration 7/2023; 92479 and 92198, expiration 8/2023; 92199 and 93040, expiration 9/2023; and 93041, expiration 10/2023.
If you have these patches, return them to the pharmacy for a full refund and inform your medical professional. If you have any questions about this recall, call Noven at 305-253-5099.
If you have any medical problems from this or any other drug, first see a medical professional. Then, let the FDA know via its MedWatch Adverse Event page or by filling out a form you can get by calling 800-332-1088.
This story was originally published March 22, 2023 at 5:05 PM.
